Insulet Corporation
137.92USD
-4.3600 (-3.06%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 802 | 762 | 784 | 706 | 649 | 569 | 598 | 544 |
| Cost of Revenue | 239 | 233 | 215 | 196 | 197 | 160 | 167 | 167 |
| Gross Profit | 563 | 529 | 569 | 510 | 452 | 409 | 431 | 377 |
| Operating Income | 130 | 122 | 146 | 118 | 121 | 89 | 109 | 88 |
| Net Income | 95 | 91 | 102 | 88 | 23 | 35 | 101 | 78 |
| EPS (Diluted) | $1.37 | $1.30 | $1.43 | $1.24 | $0.32 | $0.50 | $1.38 | $1.08 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)